We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$14.8B
AUM Growth
+$674M
(+4.8%)
Cap. Flow
-$313M
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
30.84%
Holding
634
New
84
Increased
165
Reduced
229
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$167M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$106M |
| 3 |
PF
Pinnacle Foods, Inc.
PF
|
+$65.4M |
| 4 |
Toronto Dominion Bank
TD
|
+$54.2M |
| 5 |
Royal Bank of Canada
RY
|
+$53.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$132M |
| 2 |
Apple
AAPL
|
+$125M |
| 3 |
UnitedHealth
UNH
|
+$103M |
| 4 |
Oracle
ORCL
|
+$91.5M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$86.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Healthcare | 17.53% |
| 3 | Financials | 13.26% |
| 4 | Communication Services | 8.82% |
| 5 | Consumer Discretionary | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Adtran
ADTN
$675M
| – | – |
-25,900
| Closed | -$385K |
|
527
AAR Corp
AIR
$5.4B
| – | – |
-8,300
| Closed | -$386K |
|
528
American Public Education
APEI
$940M
| – | – |
-12,025
| Closed | -$506K |
|
529
American Vanguard Corp
AVD
$68.7M
| – | – |
-33,900
| Closed | -$778K |
|
530
AstraZeneca
AZN
$269B
| – | – |
-14,350
| Closed | -$1.01M |
|
531
BGC Group
BGC
$5.64B
| – | – |
-99,987
| Closed | -$728K |
|
532
Booking.com
BKNG
$156B
| – | – |
-2,500
| Closed | -$203K |
|
533
Conagra Brands
CAG
$7.42B
| – | – |
-86,520
| Closed | -$3.09M |
|
534
Choice Hotels
CHH
$5.26B
| – | – |
-3,500
| Closed | -$265K |
|
|
CLDT
535
Chatham Lodging
CLDT
$632M
| – | – |
-11,500
| Closed | -$244K |
|
536
Celestica
CLS
$37.8B
| – | – |
-10,800
| Closed | -$128K |
|
537
Clorox
CLX
$12B
| – | – |
-3,500
| Closed | -$473K |
|
538
Centene
CNC
$30.5B
| – | – |
-12,400
| Closed | -$764K |
|
539
CNO Financial Group
CNO
$4.94B
| – | – |
-100,510
| Closed | -$1.91M |
|
540
Carter's
CRI
$1.43B
| – | – |
-17,558
| Closed | -$1.9M |
|
541
CytomX Therapeutics
CTMX
$690M
| – | – |
-14,900
| Closed | -$341K |
|
542
CALL
Dell
DELL
$239B
| – | – |
-777,499
| Closed | -$18.5M |
|
|
543
Dell
DELL
$239B
| – | – |
-2,216,338
| Closed | -$52.6M |
|
544
DXC Technology
DXC
$1.91B
| – | – |
-60,148
| Closed | -$4.85M |
|
545
Entegris
ENTG
$16.3B
| – | – |
-8,100
| Closed | -$275K |
|
546
iShares MSCI South Korea ETF
EWY
$20.1B
| – | – |
-455,100
| Closed | -$30.8M |
|
547
Exelixis
EXEL
$13.9B
| – | – |
-31,000
| Closed | -$667K |
|
548
Ford
F
$60.9B
| – | – |
-26,900
| Closed | -$298K |
|
549
Four Corners Property Trust
FCPT
$2.89B
| – | – |
-10,336
| Closed | -$255K |
|
550
Federated Hermes
FHI
$4.56B
| – | – |
-109,003
| Closed | -$2.54M |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2018 Portfolio in Review
As of Q3 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 634 positions worth $14.8B, up 4.8% from $14.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2018 filing shows 84 new, 165 increased, 229 reduced and 110 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 2,337,345 shares worth $107M. The largest sale was Johnson & Johnson, an estimated $132M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2018 buy was Twenty-First Century Fox, Inc. Class B: 2,337,345 shares worth $107M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to iShares MSCI Emerging Markets ETF in Q3 2018, an estimated $167M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $132M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Dell in Q3 2018, selling an estimated $52.6M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $14.8B portfolio in Q3 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q3 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 4.8% quarter-over-quarter to $14.8B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2018, filed 14 Nov 2018.